As part of an expedited move to address the clinical need to report and track antibody testing related to COVID-19, the American Medical Association has revised one code and established two new codes to provide increased specificity to report serologic lab testing.
The codes were published on Friday, April 10, and are effective immediately. They will be included in the 2021 edition of the CPT code set in the immunology section of the pathology and laboratory section. Commercial payment rates for these tests have not yet been announced.
- Revised: 86318 — Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single-step method (ie. reagent strip).
- New: 86328 — Severe acute respiratory syndrome coronavirus (SARS-CoV-2) Coronavirus disease (COVID-19), single-step immunoassay. For antibody testing using the multi-step method, use 86769.
- New: 86769 — Antibody; Severe acute respiratory syndrome coronavirus (SARS-CoV-2) Coronavirus disease (COVID-19). For detection of antibodies other than those to infectious agents, see specific antibody or specific method.
Clinical examples and full procedure descriptions may be viewed in the AMA guidelines below:
If you have any questions related to billing or utilizing these new codes, please don’t hesitate to reach out to us at 517-486-4262.